tx 3301 has been researched along with Brain Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer, D | 1 |
| Horie, Y; Ikeda, Y; Uchiyama, S; Urano, Y; Yamaguchi, T | 1 |
| Collins, R; Coughlan, T; Cox, D; Kinsella, JA; McCabe, DJ; Murphy, RP; O'Neill, D; Tobin, WO | 1 |
| Atar, D; Hennekens, CH; Jilma, B; Malinin, AI; Sane, DC; Serebruany, VL; Takserman, A | 1 |
| Bergmann, SR | 1 |
1 review(s) available for tx 3301 and Brain Ischemia
| Article | Year |
|---|---|
Antiplatelets and stroke outcomes: state of the science.
Topics: Arachidonic Acid; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Combinations; Evidence-Based Practice; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Risk Reduction Behavior; Safety; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
2 trial(s) available for tx 3301 and Brain Ischemia
| Article | Year |
|---|---|
The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.
Topics: Aged; Asian People; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Treatment Outcome | 2011 |
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Topics: Aged; Antigens, CD; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; CD40 Ligand; Dipyridamole; Drug Combinations; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Function Tests; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 24; Time Factors; Treatment Outcome | 2004 |
2 other study(ies) available for tx 3301 and Brain Ischemia
| Article | Year |
|---|---|
Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Brain Ischemia; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine | 2013 |
Alert to physicians: possible interaction of aggrenox and adenosine.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Vasodilator Agents | 2000 |